Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when STIM files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Departure of CEO (new) — President and CEO retired from the Company effective April 1, 2026, creating leadership transition at highest executive level.
- Departure of CFO (new) — Chief Financial Officer departing after less than one year in role (hired July 2025, resigning May 2026), which may signal instability in financial leadership despite no-dispute disclosure.
Neuronetics CEO and CFO both depart as company cuts 5% of workforce to save $2.5M-$3M annually
Filed April 6, 2026 · Period ending March 31, 2026 · ~1 min read
Key Changes
-
high
CEO Keith Sullivan retired April 1, 2026, transitioning to unpaid consultant through March 2027 while continuing to vest existing equity awards. CFO Steven Pfanstiel resigned effective May 1, 2026, after less than 10 months in role.
Items 5.02 & 7.01 view on EDGAR → -
high
Company initiated workforce reduction affecting up to 5% of employees, expecting $0.2M in Q2 2026 restructuring charges but generating $2.5M-$3M in annualized savings starting Q3 2026.
Item 2.05 verify on EDGAR → -
medium
Management reaffirmed FY2026 financial guidance originally provided March 17, 2026, despite dual C-suite departures and restructuring actions.
Item 7.01 verify on EDGAR → -
medium
CFO departure disclosed as not resulting from any dispute with management or board regarding operations, policies, or practices. Company searching for successor.
Item 5.02 verify on EDGAR → -
low
Former CEO Sullivan agreed to release employment-related legal claims and accepted standard non-compete, non-solicitation, and confidentiality restrictions through March 2027.
Item 5.02 verify on EDGAR →
Summary
Neuronetics disclosed a significant leadership shakeup with both its CEO and CFO departing within weeks of each other. CEO Keith Sullivan retired April 1st and will consult unpaid through March 2027 while vesting existing equity. More concerning, CFO Steven Pfanstiel is resigning May 1st after holding the position for less than ten months—though the company states this wasn't due to any dispute.
Simultaneously, the company is cutting up to 5% of its workforce to generate $2.5M-$3M in annual savings, absorbing just $0.2M in severance costs during Q2. For retail investors, the dual C-suite departures raise questions about strategic direction and operational stability, even as management reaffirmed prior FY2026 guidance.
The workforce reduction suggests cost pressures, though the 12-15x return on restructuring costs indicates disciplined expense management. The key question is whether these are planned transitions supporting a turnaround strategy or symptoms of deeper challenges. Watch for the Q2 2026 earnings call and the announcement of permanent CEO and CFO replacements. If the company misses reaffirmed guidance or delays naming successors, it could signal execution risk beyond normal transition friction.
Section-by-Section Diff
Event · Item 1.01 — Entry into a Material Definitive Agreement
CEO Keith J. Sullivan retired; entered consulting agreement through March 2027 with continued equity vesting but no additional compensation.
Added in current filing · verify on EDGAR →
On April 1, 2026, Neuronetics, Inc. (the “Company”) entered into an Executive Consulting and Release Agreement (the “Agreement”) with Keith J. Sullivan in connection with Mr. Sullivan’s retirement from the Company. Mr. Sullivan previously served as the Company’s President and Chief Executive Officer.
The Company's President and CEO, Keith J. Sullivan, retired effective April 1, 2026. He entered into a consulting agreement to provide services through March 31, 2027. This represents a leadership transition at the highest executive level.
Added in current filing · verify on EDGAR →
Mr. Sullivan is not entitled to any additional compensation for his consulting services. However, during the term of his consultancy, Mr. Sullivan will continue to vest in his outstanding equity awards in accordance with the original terms thereof.
The former CEO will receive no cash compensation for consulting services but will continue vesting in existing equity awards through March 2027. This arrangement allows continued equity-based retention without additional cash outlay.
Added in current filing · verify on EDGAR →
Pursuant to the Agreement, Mr. Sullivan will provide a release of legal claims relating to his employment with the Company as well as specified consulting services to the Company through March 31, 2027. ... The Agreement also contains customary restrictive covenants, including confidentiality, non-solicitation, and non-competition.
Mr. Sullivan agreed to release employment-related legal claims and accepted standard post-employment restrictions on confidentiality, solicitation, and competition. These provisions protect the Company from potential litigation and competitive risks during the transition period.
Event · Item 2.05 — Costs Associated with Exit or Disposal Activities
Item 2.05 — Costs Associated with Exit or Disposal Activities filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
On April 2, 2026, the Company initiated a workforce reduction, which it expects to be completed by mid-year 2026, that will impact up to 5% of its employees.
The company announced a workforce reduction affecting up to 5% of employees, to be completed by mid-2026. This is part of a cost optimization effort.
Added in current filing · verify on EDGAR →
The Company expects to incur restructuring charges of approximately $0.2 million, primarily for severance and related costs, in the second quarter of 2026.
The company will record approximately $0.2 million in restructuring charges during Q2 2026, primarily for severance and related employee costs associated with the workforce reduction.
Event · Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
On March 31, 2026, Steven E. Pfanstiel, who has served as Executive Vice President, Chief Financial Officer, and Treasurer since July 15, 2025, informed the Company of his intention to resign on May 1, 2026.
The company's CFO, who has held the position for less than ten months, announced his resignation effective May 1, 2026. The company has begun searching for a replacement. While the filing states the departure is not due to any dispute with management or the board, CFO turnover can signal instability in financial leadership.
Added in current filing · verify on EDGAR →
Mr. Pfanstiel’s decision to resign is not the result of any dispute or disagreement with the Company, the Company’s management, or the Company’s Board of Directors on any matter relating to the Company’s operations, policies, or practices.
The company explicitly disclosed that the CFO's resignation was not due to any disagreement or dispute regarding operations, policies, or practices. This is standard language in departure disclosures to clarify the nature of the separation.
Event · Item 7.01 — Regulation FD Disclosure
Item 7.01 — Regulation FD Disclosure filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
the Company released a press release announcing the transition of its Executive Vice President, Chief Financial Officer, and Treasurer
Neuronetics disclosed that its Executive Vice President, Chief Financial Officer, and Treasurer is transitioning out of the role. The 8-K does not provide details about the reason for departure, timing, or successor. CFO changes can impact investor confidence and may signal strategic shifts or operational challenges.
Added in current filing · verify on EDGAR →
reaffirmed the financial guidance it provided during its fourth quarter 2025 earnings call on March 17, 2026
The company reaffirmed its previously issued financial guidance for fiscal year 2026, which was originally provided during the Q4 2025 earnings call on March 17, 2026. This reaffirmation suggests management confidence in meeting prior projections despite the CFO transition.
Event · Item 9.01 — Financial Statements and Exhibits
Neuronetics disclosed CFO transition with consulting agreement for departing Keith J. Sullivan effective April 1, 2026.
Added in current filing · verify on EDGAR →
Executive Consulting and Release Agreement by and between the Company and Keith J. Sullivan dated April 1, 2026
Neuronetics entered into an Executive Consulting and Release Agreement with Keith J. Sullivan, the departing CFO, effective April 1, 2026. This indicates a leadership transition at the CFO position with a consulting arrangement for the outgoing executive. The release agreement component suggests a negotiated separation with mutual releases of claims.
Added in current filing · verify on EDGAR →
Neuronetics Announces Chief Financial Officer Transition
The company issued a press release announcing the Chief Financial Officer transition. CFO changes are material events that can impact financial reporting, investor relations, and strategic execution. Investors should review the full press release for details on the successor CFO and reasons for the transition.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 3, 2026 · How we verify